Brendan Dignan > Baker Botts L.L.P. > Washington DC, United States > Lawyer Profile
Baker Botts L.L.P. Offices
700 K Street, N.W.
Washington, D.C. 20001-5692
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Brendan Dignan
Work Department
Corporate
Position
Partner
BB Vets Affinity Group Chair
Career
Brendan advises public and private companies, including private equity sponsors and their portfolio companies, in a wide variety of complex business transactions including mergers and acquisitions, leveraged buyouts, and joint ventures, as well as operational and corporate governance strategy. He has experience counseling clients in a number of industries including manufacturing, aerospace and defense, technology, media, telecommunications, chemicals, and consumer products.
Before practicing law, Brendan served in the Middle East and Europe for four years as a U.S. Army Field Artillery and Cavalry officer. He applies the management skills acquired during his service to strategically guide deals from initial structuring to closing. He is the firmwide chair of Baker Botts’ military veteran affinity group, “BB Vets.”
Memberships
District of Columbia Bar
New York State Bar
Education
J.D., University of Virginia School of Law 2008
Mary Claiborne and Roy H. Ritter Scholar
B.A., University of Virginia 2001
Top Tier Firm Rankings
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- International Trade > Customs, export controls and economic sanctions
Firm Rankings
- Antitrust > Cartel
- Energy > Energy litigation: electric power
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Tax > US taxes: contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Labor and employment > ERISA litigation
- Dispute resolution > International arbitration
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- Energy > Renewable/alternative power
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Finance > Capital markets: equity offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Real estate > Construction (including construction litigation)
- Healthcare > Life sciences
- Real estate > Real estate
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense